4D Molecular Therapeutics Ownership 2024 | Who Owns 4D Molecular Therapeutics Now?
Institutional Ownership
116.37%
Insider Ownership
3.48%
Retail Ownership
-19.85%
Institutional Holders
146.00
4D Molecular Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 10.35% | 1.42% | 5,098,211 | 46,700 | 0.92% | 107,011,449 | Jun 30, 2024 |
| BLACKROCK INC. | 9.94% | 0.00% | 4,896,897 | 612,349 | 14.29% | 102,785,867 | Jun 30, 2024 |
| VR ADVISER, LLC | 8.93% | 5.88% | 4,400,000 | - | - | 92,356,000 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 8.39% | 0.01% | 4,134,254 | 1,076,405 | 35.20% | 86,777,991 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 8.24% | 2.54% | 4,061,401 | 1,026,948 | 33.84% | 85,248,807 | Jun 30, 2024 |
| BVF INC/IL | 7.96% | 2.31% | 3,922,413 | - | - | 82,331,449 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 6.49% | 0.04% | 3,196,762 | -682 | -0.02% | 67,108,929 | Jun 30, 2024 |
| VIKING GLOBAL INVESTORS LP | 5.96% | 0.24% | 2,934,914 | - | - | 61,603,845 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.13% | 0.00% | 2,528,180 | 188,237 | 8.04% | 53,066,498 | Jun 30, 2024 |
| STATE STREET CORP | 4.22% | 0.00% | 2,079,276 | -98,954 | -4.54% | 43,644,003,000 | Jun 30, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 3.54% | 0.22% | 1,744,857 | -53,635 | -2.98% | 36,624,548 | Jun 30, 2024 |
| MORGAN STANLEY | 2.96% | 0.00% | 1,460,234 | -89,492 | -5.77% | 30,650,321 | Jun 30, 2024 |
| NOVO HOLDINGS A/S | 2.84% | 1.71% | 1,400,000 | - | - | 29,386,000 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 2.18% | 1.36% | 1,073,435 | -187,992 | -14.90% | 22,531,401 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.15% | 0.00% | 1,060,891 | 188,228 | 21.57% | 22,272,188 | Jun 30, 2024 |
| FMR LLC | 2.06% | 0.00% | 1,016,223 | 47,341 | 4.89% | 21,330,521 | Jun 30, 2024 |
| EVENTIDE ASSET MANAGEMENT, LLC | 1.79% | 0.32% | 881,157 | 105,043 | 13.53% | 18,495,485 | Jun 30, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | 1.73% | 0.21% | 850,201 | -228,124 | -21.16% | 17,845,719 | Jun 30, 2024 |
| CASDIN CAPITAL, LLC | 1.62% | 1.29% | 800,000 | - | - | 16,792,000 | Jun 30, 2024 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 1.43% | 0.04% | 706,000 | 65,000 | 10.14% | 14,818,940 | Jun 30, 2024 |
4D Molecular Therapeutics's largest institutional shareholder is RA CAPITAL MANAGEMENT, L.P., holding 10.35% of the company's total share outstanding, currently valued at $107.01M. The top 10 institutional shareholders own together 75.61% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VR ADVISER, LLC | 8.93% | 5.88% | 4,400,000 | - | - | 92,356,000 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 8.24% | 2.54% | 4,061,401 | 1,026,948 | 33.84% | 85,248,807 | Jun 30, 2024 |
| BVF INC/IL | 7.96% | 2.31% | 3,922,413 | - | - | 82,331,449 | Jun 30, 2024 |
| DECHENG CAPITAL LLC | 0.71% | 2.24% | 347,835 | - | - | 7,301,057 | Jun 30, 2024 |
| NOVO HOLDINGS A/S | 2.84% | 1.71% | 1,400,000 | - | - | 29,386,000 | Jun 30, 2024 |
| EAGLE HEALTH INVESTMENTS LP | 0.94% | 1.70% | 462,911 | - | - | 9,716,502 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 0.70% | 1.66% | 345,750 | 1,627 | 0.47% | 7,257,293 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 10.35% | 1.42% | 5,098,211 | 46,700 | 0.92% | 107,011,449 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 2.18% | 1.36% | 1,073,435 | -187,992 | -14.90% | 22,531,401 | Jun 30, 2024 |
| CASDIN CAPITAL, LLC | 1.62% | 1.29% | 800,000 | - | - | 16,792,000 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.49% | 0.69% | 242,526 | 80,365 | 49.56% | 5,090,621 | Jun 30, 2024 |
| EVENTIDE ASSET MANAGEMENT, LLC | 1.79% | 0.32% | 881,157 | 105,043 | 13.53% | 18,495,485 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 0.55% | 0.30% | 271,155 | 72,969 | 36.82% | 5,691,543 | Jun 30, 2024 |
| BRAIDWELL LP | 0.75% | 0.24% | 369,458 | -683,027 | -64.90% | 7,754,923 | Jun 30, 2024 |
| VIKING GLOBAL INVESTORS LP | 5.96% | 0.24% | 2,934,914 | - | - | 61,603,845 | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | 0.01% | 0.22% | 7,265 | 7,265 | 100.00% | 152,492 | Jun 30, 2024 |
| PELOTON WEALTH STRATEGISTS | 0.05% | 0.22% | 25,000 | - | - | 525,000 | Jun 30, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 3.54% | 0.22% | 1,744,857 | -53,635 | -2.98% | 36,624,548 | Jun 30, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | 1.73% | 0.21% | 850,201 | -228,124 | -21.16% | 17,845,719 | Jun 30, 2024 |
| PRIVIUM FUND MANAGEMENT B.V. | 0.08% | 0.21% | 40,000 | 9,000 | 29.03% | 823,200 | Jun 30, 2024 |
The largest 4D Molecular Therapeutics shareholder by % of total assets is VR ADVISER, LLC. The company owns 4.40M shares of 4D Molecular Therapeutics (FDMT), representing 5.88% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| GOLDMAN SACHS GROUP INC | 8.39% | 0.01% | 4,134,254 | 1,076,405 | 35.20% | 86,777,991 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 8.24% | 2.54% | 4,061,401 | 1,026,948 | 33.84% | 85,248,807 | Jun 30, 2024 |
| BLACKROCK INC. | 9.94% | 0.00% | 4,896,897 | 612,349 | 14.29% | 102,785,867 | Jun 30, 2024 |
| PANAGORA ASSET MANAGEMENT INC | 0.72% | 0.04% | 354,857 | 252,789 | 247.67% | 7,448,448 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.13% | 0.00% | 2,528,180 | 188,237 | 8.04% | 53,066,498 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.15% | 0.00% | 1,060,891 | 188,228 | 21.57% | 22,272,188 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.46% | 0.00% | 227,599 | 119,690 | 110.92% | 4,777,304 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 0.23% | 0.01% | 113,300 | 113,300 | 100.00% | 2,378,167 | Jun 30, 2024 |
| EVENTIDE ASSET MANAGEMENT, LLC | 1.79% | 0.32% | 881,157 | 105,043 | 13.53% | 18,495,485 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.22% | 0.00% | 110,041 | 95,422 | 652.73% | 2,309,761 | Jun 30, 2024 |
| NISA INVESTMENT ADVISORS, LLC | 0.20% | 0.01% | 96,698 | 95,041 | 5735.73% | 2,029,691 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.49% | 0.69% | 242,526 | 80,365 | 49.56% | 5,090,621 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 0.55% | 0.30% | 271,155 | 72,969 | 36.82% | 5,691,543 | Jun 30, 2024 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 1.43% | 0.04% | 706,000 | 65,000 | 10.14% | 14,818,940 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.13% | 0.10% | 64,882 | 64,882 | 100.00% | 1,362,000 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.18% | 0.00% | 86,456 | 62,065 | 254.46% | 1,814,712 | Jun 30, 2024 |
| TWINBEECH CAPITAL LP | 0.12% | 0.02% | 58,619 | 58,619 | 100.00% | 1,230,413 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.10% | 0.01% | 49,945 | 49,945 | 100.00% | 1,048,000 | Jun 30, 2024 |
| FMR LLC | 2.06% | 0.00% | 1,016,223 | 47,341 | 4.89% | 21,330,521 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 10.35% | 1.42% | 5,098,211 | 46,700 | 0.92% | 107,011,449 | Jun 30, 2024 |
As of Jun 30 2024, 4D Molecular Therapeutics's largest institutional buyer is GOLDMAN SACHS GROUP INC. The company purchased 1.08M stocks of FDMT, valued at $86.78M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BRAIDWELL LP | 0.75% | 0.24% | 369,458 | -683,027 | -64.90% | 7,754,923 | Jun 30, 2024 |
| LMR PARTNERS LLP | - | - | - | -487,533 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | 0.14% | 0.00% | 67,140 | -307,050 | -82.06% | 1,409,269 | Jun 30, 2024 |
| CANDRIAM S.C.A. | - | - | - | -269,000 | -100.00% | - | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | - | - | - | -257,600 | -100.00% | - | Jun 30, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | - | - | - | -250,000 | -100.00% | - | Jun 30, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | 1.73% | 0.21% | 850,201 | -228,124 | -21.16% | 17,845,719 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.08% | 0.00% | 532,742 | -216,250 | -28.87% | 11,182,125 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 2.18% | 1.36% | 1,073,435 | -187,992 | -14.90% | 22,531,401 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -125,000 | -100.00% | - | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | - | - | - | -113,590 | -100.00% | - | Jun 30, 2024 |
| BAKER BROS. ADVISORS LP | - | - | - | -100,000 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | 4.22% | 0.00% | 2,079,276 | -98,954 | -4.54% | 43,644,003,000 | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.19% | 0.01% | 95,565 | -96,816 | -50.33% | 2,005,909 | Jun 30, 2024 |
| EAM INVESTORS, LLC | - | - | - | -96,225 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | 2.96% | 0.00% | 1,460,234 | -89,492 | -5.77% | 30,650,321 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 0.22% | 0.20% | 108,598 | -88,500 | -44.90% | 2,279,472 | Jun 30, 2024 |
| GHISALLO CAPITAL MANAGEMENT LLC | - | - | - | -80,000 | -100.00% | - | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | - | - | - | -75,000 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.38% | 0.01% | 185,866 | -71,880 | -27.89% | 3,901,327 | Jun 30, 2024 |
As of Jun 30 2024, 4D Molecular Therapeutics's biggest institutional seller is BRAIDWELL LP. The company sold -0.68M shares of FDMT, valued at $7.75M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| HUDSON BAY CAPITAL MANAGEMENT LP | 0.23% | 0.01% | 113,300 | 113,300 | 100.00% | 2,378,167 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.13% | 0.10% | 64,882 | 64,882 | 100.00% | 1,362,000 | Jun 30, 2024 |
| TWINBEECH CAPITAL LP | 0.12% | 0.02% | 58,619 | 58,619 | 100.00% | 1,230,413 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.10% | 0.01% | 49,945 | 49,945 | 100.00% | 1,048,000 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.08% | 0.00% | 39,415 | 39,415 | 100.00% | 827,321 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.06% | 0.01% | 28,385 | 28,385 | 100.00% | 595,801 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 26,808 | 26,808 | 100.00% | 562,700 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.05% | 0.00% | 24,749 | 24,749 | 100.00% | 519,265 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | 0.04% | 0.00% | 17,435 | 17,435 | 100.00% | 365,962 | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | 0.03% | 0.06% | 15,578 | 15,578 | 100.00% | 326,982 | Jun 30, 2024 |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 0.03% | 0.01% | 14,649 | 14,649 | 100.00% | 307,483 | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | 0.03% | 0.00% | 14,471 | 14,471 | 100.00% | 303,746 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.03% | 0.00% | 14,273 | 14,273 | 100.00% | 299,589 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.03% | 0.02% | 13,536 | 13,536 | 100.00% | 284,121 | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | 0.03% | 0.00% | 12,787 | 12,787 | 100.00% | 268,399 | Jun 30, 2024 |
| CANTOR FITZGERALD, L. P. | 0.03% | 0.05% | 12,500 | 12,500 | 100.00% | 262,375 | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 0.02% | 0.00% | 11,079 | 11,079 | 100.00% | 232,548 | Jun 30, 2024 |
| BRIDGEFRONT CAPITAL, LLC | 0.02% | 0.09% | 10,171 | 10,171 | 100.00% | 213,489 | Jun 30, 2024 |
| CAPSTONE INVESTMENT ADVISORS, LLC | 0.02% | 0.00% | 9,548 | 9,548 | 100.00% | 200,413 | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | 0.01% | 0.22% | 7,265 | 7,265 | 100.00% | 152,492 | Jun 30, 2024 |
| AQUATIC CAPITAL MANAGEMENT LLC | 0.01% | 0.00% | 5,100 | 5,100 | 100.00% | 107,049 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.00% | 0.00% | 2,308 | 2,308 | 100.00% | 48,444 | Jun 30, 2024 |
| PACIFIC CENTER FOR FINANCIAL SERVICES | 0.00% | 0.00% | 207 | 207 | 100.00% | 4,345 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | 0.00% | 0.00% | 81 | 81 | 100.00% | 1,695 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | - | - | 4 | 4 | 100.00% | 84 | Jun 30, 2024 |
4D Molecular Therapeutics's largest new institutional shareholder by number of shares is HUDSON BAY CAPITAL MANAGEMENT LP, purchased 113.30K shares, valued at $2.38M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| LMR PARTNERS LLP | - | - | - | -487,533 | -100.00% | - | Jun 30, 2024 |
| CANDRIAM S.C.A. | - | - | - | -269,000 | -100.00% | - | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | - | - | - | -257,600 | -100.00% | - | Jun 30, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | - | - | - | -250,000 | -100.00% | - | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -125,000 | -100.00% | - | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | - | - | - | -113,590 | -100.00% | - | Jun 30, 2024 |
| BAKER BROS. ADVISORS LP | - | - | - | -100,000 | -100.00% | - | Jun 30, 2024 |
| EAM INVESTORS, LLC | - | - | - | -96,225 | -100.00% | - | Jun 30, 2024 |
| GHISALLO CAPITAL MANAGEMENT LLC | - | - | - | -80,000 | -100.00% | - | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | - | - | - | -75,000 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -69,833 | -100.00% | - | Jun 30, 2024 |
| SOROS FUND MANAGEMENT LLC | - | - | - | -62,500 | -100.00% | - | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | - | - | - | -29,895 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -20,020 | -100.00% | - | Jun 30, 2024 |
| CONCURRENT INVESTMENT ADVISORS, LLC | - | - | - | -17,325 | -100.00% | - | Jun 30, 2024 |
| SEI INVESTMENTS CO | - | - | - | -15,818 | -100.00% | - | Jun 30, 2024 |
| PROSHARE ADVISORS LLC | - | - | - | -10,788 | -100.00% | - | Jun 30, 2024 |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC | - | - | - | -10,472 | -100.00% | - | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | - | - | - | -8,821 | -100.00% | - | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -8,634 | -100.00% | - | Jun 30, 2024 |
| VIDENT ADVISORY, LLC | - | - | - | -8,600 | -100.00% | - | Jun 30, 2024 |
| ENTROPY TECHNOLOGIES, LP | - | - | - | -7,487 | -100.00% | - | Jun 30, 2024 |
| ARIZONA STATE RETIREMENT SYSTEM | - | - | - | -7,458 | -100.00% | - | Jun 30, 2024 |
| DNB ASSET MANAGEMENT AS | - | - | - | -7,363 | -100.00% | - | Jun 30, 2024 |
| E FUND MANAGEMENT CO., LTD. | - | - | - | -7,351 | -100.00% | - | Jun 30, 2024 |
| BELVEDERE TRADING LLC | - | - | - | -4,800 | -100.00% | - | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -4,741 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -4,583 | -100.00% | - | Jun 30, 2024 |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | - | - | - | -3,457 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -2,164 | -100.00% | - | Jun 30, 2024 |
| CLEAR STREET MARKETS LLC | - | - | - | -142 | -100.00% | - | Jun 30, 2024 |
| FEDERATED HERMES, INC. | - | - | - | -27 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -8 | -100.00% | - | Jun 30, 2024 |
| ROTHSCHILD INVESTMENT LLC | - | - | - | -5 | -100.00% | - | Jun 30, 2024 |
4D Molecular Therapeutics's largest sold out institutional shareholder by shares sold is LMR PARTNERS LLP, sold -0.49M shares, valued at -, as of undefined.
4D Molecular Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| CORNERCAP GROUP OF FUNDS /VA/ | 0.14% | 10,354 | - | - | Sep 30, 2022 |
| MERIDIAN FUND INC | 0.11% | 266,383 | -88,184 | -24.87% | Mar 28, 2024 |
| BlackRock Health Sciences Trust | 0.07% | 17,173 | 17,173 | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.06% | 146,438 | 51,108 | 53.61% | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.05% | 26,726 | - | - | Mar 31, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.03% | 5,279 | - | - | Mar 28, 2024 |
| Advantage Advisers Xanthus Fund, L.L.C. | 0.03% | 80,783 | - | - | Mar 31, 2024 |
| Voya EQUITY TRUST | 0.02% | 31,443 | - | - | Feb 29, 2024 |
| Humankind Benefit Corp | 0.02% | 366 | 84 | 29.79% | Dec 31, 2023 |
| ROYCE MICRO-CAP TRUST, INC. | 0.01% | 7,038 | -11,731 | -62.50% | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.01% | 356,900 | 316,891 | 792.05% | Feb 29, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 70,545 | -2,465 | -3.38% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 6,128 | - | - | Mar 31, 2024 |
| Federated Hermes Equity Funds | 0.01% | 150,000 | - | - | Jan 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.01% | 13,500 | - | - | Mar 28, 2024 |
| VANGUARD EXPLORER FUND | 0.00% | 59,968 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 2,027,611 | -32,493 | -1.58% | Mar 31, 2024 |
| FIDELITY SECURITIES FUND | 0.00% | 375,670 | - | - | Jan 31, 2024 |
| ETFis Series Trust I | 0.00% | 4,941 | 462 | 10.31% | Jan 31, 2024 |
| JANUS INVESTMENT FUND | 0.00% | 1,026,642 | 122,450 | 13.54% | Dec 31, 2023 |
| Fidelity Commonwealth Trust II | 0.00% | 19,877 | - | - | Aug 31, 2023 |
| SCHWAB CAPITAL TRUST | 0.00% | 108,533 | 2,016 | 1.89% | Jan 31, 2024 |
| ALPS ETF Trust | 0.00% | 31,262 | 10,798 | 52.77% | Feb 29, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 524 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 351,506 | 69,088 | 24.46% | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 3,929 | - | - | Mar 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 2,704 | 2,704 | - | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 29,224 | 4,294 | 17.22% | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 77,125 | - | - | Jan 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 121,612 | -13,584 | -10.05% | Jan 31, 2024 |
| ProFunds | 0.00% | 8,213 | 3,087 | 60.22% | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 614,059 | 207,452 | 51.02% | Jan 31, 2024 |
| Forethought Variable Insurance Trust | 0.00% | 2,500 | - | - | Mar 28, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 10,808 | -179 | -1.63% | Jan 31, 2024 |
| Dimensional ETF Trust | 0.00% | 225,249 | 65,669 | 41.15% | Jan 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 13,699 | -1,406 | -9.31% | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 13,271 | -2,609 | -16.43% | Mar 31, 2024 |
| Global X Funds | 0.00% | 17,635 | 3,715 | 26.69% | Jan 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 4,739 | -390 | -7.60% | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,882 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 24,264 | - | - | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 8,264 | 236 | 2.94% | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 193,710 | 39,703 | 25.78% | Feb 29, 2024 |
| VANGUARD WORLD FUND | 0.00% | 77,868 | - | - | Feb 29, 2024 |
| NORTHERN FUNDS | 0.00% | 39,525 | -4,479 | -10.18% | Mar 28, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 684 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 14,400 | 1,300 | 9.92% | Mar 31, 2024 |
| BlackRock ETF Trust | 0.00% | 184 | 7 | 3.95% | Jan 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 852 | 852 | - | Mar 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 56,197 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 1,754 | 181 | 11.51% | Mar 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 10,876 | 6,044 | 125.08% | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 1,840,019 | -17,271 | -0.93% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 176,090 | 22,298 | 14.50% | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 105,187 | 4,739 | 4.72% | Mar 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.00% | 934 | - | - | Jan 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 343 | - | - | Dec 31, 2023 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 763 | 763 | - | Mar 28, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 8,021 | 2,113 | 35.77% | Mar 31, 2024 |
| VALIC Co I | 0.00% | 15,335 | 232 | 1.54% | Feb 29, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 2,535 | - | - | Dec 31, 2023 |
| RYDEX DYNAMIC FUNDS | 0.00% | 179 | 36 | 25.17% | Dec 31, 2023 |
| RBB FUND, INC. | 0.00% | 3,970 | - | - | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 1,200 | -300 | -20.00% | Mar 28, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 5,162 | -27 | -0.52% | Jan 31, 2024 |
| PROSHARES TRUST | 0.00% | 9,049 | 1,301 | 16.79% | Feb 29, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 3,406 | -4,070 | -54.44% | Feb 29, 2024 |
| SPDR SERIES TRUST | 0.00% | 1,296,013 | 533,498 | 69.97% | Mar 31, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 6,913 | - | - | Feb 29, 2024 |
| FLEXSHARES TRUST | 0.00% | 2,232 | - | - | Jan 31, 2024 |
| MAINSTAY FUNDS TRUST | 0.00% | 5,670 | 5,670 | - | Jan 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 83,756 | - | - | Jan 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 162 | - | - | Feb 29, 2024 |
| Franklin Templeton ETF Trust | 0.00% | 5,013 | 1,871 | 59.55% | Mar 31, 2024 |
| MAINSTAY VP FUNDS TRUST | 0.00% | 2,988 | 2,988 | - | Mar 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 662 | - | - | Mar 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 1,359 | - | - | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 22,403 | - | - | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 51,967 | 2,900 | 5.91% | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 4,802 | 828 | 20.84% | Jan 31, 2024 |
| MORGAN STANLEY INSTITUTIONAL FUND INC | 0.00% | 1,273 | - | - | Mar 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 19 | - | - | Dec 31, 2023 |
| Brighthouse Funds Trust II | 0.00% | 13,421 | - | - | Mar 31, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 43,083 | 6,777 | 18.67% | Dec 31, 2023 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,467 | - | - | Feb 29, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 1,500 | -200 | -11.76% | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 4,527 | 68 | 1.53% | Jan 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 717 | - | - | Feb 29, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 4,766 | - | - | Jan 31, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 4,177 | - | - | Feb 29, 2024 |
| Pacer Funds Trust | 0.00% | 467 | -725 | -60.82% | Jan 31, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 2,916 | - | - | Jan 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 27,985 | 12,213 | 77.43% | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 158 | - | - | Jan 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 29,257 | -99 | -0.34% | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 15,075 | 180 | 1.21% | Mar 31, 2024 |
| Investment Managers Series Trust II | 0.00% | 80 | 80 | - | Mar 31, 2024 |
| SPDR INDEX SHARES FUNDS | 0.00% | 1,117 | 60 | 5.68% | Mar 31, 2024 |
| GOLDMAN SACHS TRUST | 0.00% | 16,745 | -3,494 | -17.26% | Jan 31, 2024 |
| ALLSPRING FUNDS TRUST | 0.00% | 2,009 | 2,009 | - | Mar 31, 2024 |
4D Molecular Therapeutics's largest mutual fund holder by % of total assets is "CORNERCAP GROUP OF FUNDS /VA/", owning 10.35K shares, compromising 0.14% of its total assets.
4D Molecular Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 146 | -6.41% |
| 31 Mar, 24 | 156 | 33.33% |
| 31 Dec, 23 | 117 | 1.74% |
| 30 Sep, 23 | 115 | 8.49% |
| 30 Jun, 23 | 106 | 8.16% |
| 31 Mar, 23 | 98 | -3.92% |
| 31 Dec, 22 | 102 | 17.24% |
| 30 Sep, 22 | 87 | -4.40% |
| 30 Jun, 22 | 91 | 12.35% |
| 31 Mar, 22 | 81 | 2.53% |
| 31 Dec, 21 | 79 | 23.44% |
| 30 Sep, 21 | 64 | 16.36% |
| 30 Jun, 21 | 55 | -14.06% |
| 31 Mar, 21 | 64 | 23.08% |
| 31 Dec, 20 | 52 | - |
| 30 Sep, 11 | 1 | - |
As of 30 Jun 24, 146 institutions are holding 4D Molecular Therapeutics's shares, representing a decrease of -6.41% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 57,338,955 | 1.87% |
| 31 Mar, 24 | 56,284,675 | 32.64% |
| 31 Dec, 23 | 42,433,938 | 1.23% |
| 30 Sep, 23 | 41,916,662 | 1.06% |
| 30 Jun, 23 | 41,475,360 | 36.41% |
| 31 Mar, 23 | 30,404,118 | 8.59% |
| 31 Dec, 22 | 27,999,927 | 6.99% |
| 30 Sep, 22 | 26,171,270 | 0.43% |
| 30 Jun, 22 | 26,059,449 | -0.33% |
| 31 Mar, 22 | 26,146,171 | 5.84% |
| 31 Dec, 21 | 24,703,105 | 28.76% |
| 30 Sep, 21 | 19,185,563 | 15.49% |
| 30 Jun, 21 | 16,612,726 | 7.98% |
| 31 Mar, 21 | 15,384,544 | 5.42% |
| 31 Dec, 20 | 14,593,044 | - |
| 30 Sep, 11 | 250,475 | - |
4D Molecular Therapeutics (FDMT) has 57.34M shares outstanding as of 30 Jun 24, up 1.87% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 116.37% | 0.89% |
| 31 Mar, 24 | 114.23% | 0.97% |
| 31 Dec, 23 | 108.44% | 1.10% |
| 30 Sep, 23 | 99.20% | 0.85% |
| 30 Jun, 23 | 108.19% | 1.25% |
| 31 Mar, 23 | 92.91% | 1.25% |
| 31 Dec, 22 | 86.19% | 1.32% |
| 30 Sep, 22 | 80.81% | 1.24% |
| 30 Jun, 22 | 80.72% | 1.23% |
| 31 Mar, 22 | 81.12% | 1.02% |
| 31 Dec, 21 | 89.08% | 1.77% |
| 30 Sep, 21 | 71.00% | 1.84% |
| 30 Jun, 21 | 62.13% | 1.87% |
| 31 Mar, 21 | 57.64% | 1.93% |
| 31 Dec, 20 | 54.69% | - |
| 30 Sep, 11 | 1.69% | - |
As of 30 Jun 24, 4D Molecular Therapeutics is held by 116.37% institutional shareholders, representing a 0.89% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 82 | -21.15% |
| 31 Mar, 24 | 104 | 62.50% |
| 31 Dec, 23 | 64 | 1.59% |
| 30 Sep, 23 | 63 | -11.27% |
| 30 Jun, 23 | 71 | 39.22% |
| 31 Mar, 23 | 51 | -8.93% |
| 31 Dec, 22 | 56 | 40.00% |
| 30 Sep, 22 | 40 | -24.53% |
| 30 Jun, 22 | 53 | 23.26% |
| 31 Mar, 22 | 43 | -32.81% |
| 31 Dec, 21 | 64 | 45.45% |
| 30 Sep, 21 | 44 | 10.00% |
| 30 Jun, 21 | 40 | -2.44% |
| 31 Mar, 21 | 41 | -21.15% |
| 31 Dec, 20 | 52 | - |
| 30 Sep, 11 | 1 | - |
82 institutional shareholders have increased their position in FDMT stock as of 30 Jun 24 compared to 104 in the previous quarter (a -21.15% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 38 | 2.70% |
| 31 Mar, 24 | 37 | 32.14% |
| 31 Dec, 23 | 28 | -15.15% |
| 30 Sep, 23 | 33 | 73.68% |
| 30 Jun, 23 | 19 | -26.92% |
| 31 Mar, 23 | 26 | -21.21% |
| 31 Dec, 22 | 33 | 13.79% |
| 30 Sep, 22 | 29 | 38.10% |
| 30 Jun, 22 | 21 | -19.23% |
| 31 Mar, 22 | 26 | 225.00% |
| 31 Dec, 21 | 8 | -27.27% |
| 30 Sep, 21 | 11 | - |
| 30 Jun, 21 | 11 | -15.38% |
| 31 Mar, 21 | 13 | - |
| 31 Dec, 20 | - | - |
| 30 Sep, 11 | - | - |
38 institutional shareholders have reduced their position in FDMT stock as of 30 Jun 24 compared to 37 in the previous quarter (a 2.70% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 146 | -6.41% | 57,338,955 | 1.87% | 116.37% | 0.89% | 82 | -21.15% | 38 | 2.70% |
| 31 Mar, 24 | 156 | 33.33% | 56,284,675 | 32.64% | 114.23% | 0.97% | 104 | 62.50% | 37 | 32.14% |
| 31 Dec, 23 | 117 | 1.74% | 42,433,938 | 1.23% | 108.44% | 1.10% | 64 | 1.59% | 28 | -15.15% |
| 30 Sep, 23 | 115 | 8.49% | 41,916,662 | 1.06% | 99.20% | 0.85% | 63 | -11.27% | 33 | 73.68% |
| 30 Jun, 23 | 106 | 8.16% | 41,475,360 | 36.41% | 108.19% | 1.25% | 71 | 39.22% | 19 | -26.92% |
| 31 Mar, 23 | 98 | -3.92% | 30,404,118 | 8.59% | 92.91% | 1.25% | 51 | -8.93% | 26 | -21.21% |
| 31 Dec, 22 | 102 | 17.24% | 27,999,927 | 6.99% | 86.19% | 1.32% | 56 | 40.00% | 33 | 13.79% |
| 30 Sep, 22 | 87 | -4.40% | 26,171,270 | 0.43% | 80.81% | 1.24% | 40 | -24.53% | 29 | 38.10% |
| 30 Jun, 22 | 91 | 12.35% | 26,059,449 | -0.33% | 80.72% | 1.23% | 53 | 23.26% | 21 | -19.23% |
| 31 Mar, 22 | 81 | 2.53% | 26,146,171 | 5.84% | 81.12% | 1.02% | 43 | -32.81% | 26 | 225.00% |
| 31 Dec, 21 | 79 | 23.44% | 24,703,105 | 28.76% | 89.08% | 1.77% | 64 | 45.45% | 8 | -27.27% |
| 30 Sep, 21 | 64 | 16.36% | 19,185,563 | 15.49% | 71.00% | 1.84% | 44 | 10.00% | 11 | - |
| 30 Jun, 21 | 55 | -14.06% | 16,612,726 | 7.98% | 62.13% | 1.87% | 40 | -2.44% | 11 | -15.38% |
| 31 Mar, 21 | 64 | 23.08% | 15,384,544 | 5.42% | 57.64% | 1.93% | 41 | -21.15% | 13 | - |
| 31 Dec, 20 | 52 | - | 14,593,044 | - | 54.69% | - | 52 | - | - | - |
| 30 Sep, 11 | 1 | - | 250,475 | - | 1.69% | - | 1 | - | - | - |
4D Molecular Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of 4D Molecular Therapeutics's stock was made by BVF PARTNERS L P/IL on Aug 01 2024, selling - shares at - per share (valued at -).
4D Molecular Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 7 | 11 | 63.64% |
| Q2 2024 | 17 | 17 | 100.00% |
| Q1 2024 | 13 | 27 | 48.15% |
| Q4 2023 | 6 | 2 | 300.00% |
| Q3 2023 | - | - | - |
| Q2 2023 | 14 | 10 | 140.00% |
| Q1 2023 | 5 | 11 | 45.45% |
| Q4 2022 | 3 | 14 | 21.43% |
| Q3 2022 | 5 | 1 | 500.00% |
| Q2 2022 | 9 | 3 | 300.00% |
| Q1 2022 | 4 | 1 | 400.00% |
| Q4 2021 | - | 3 | - |
| Q3 2021 | - | 15 | - |
| Q2 2021 | 10 | 1 | 1000.00% |
| Q1 2021 | 3 | - | - |
| Q4 2020 | 13 | 24 | 54.17% |
7 total buy trades, and 11 total sell trades (buy/sell ratio of 0.64%) were made by 4D Molecular Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 4 | - |
| Q2 2024 | - | 6 | - |
| Q1 2024 | - | 13 | - |
| Q4 2023 | - | 2 | - |
| Q3 2023 | - | - | - |
| Q2 2023 | 1 | 4 | 25.00% |
| Q1 2023 | - | 6 | - |
| Q4 2022 | - | 11 | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | 3 | - |
| Q3 2021 | - | 15 | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | 5 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 4 open market sell trades of 4D Molecular Therapeutics's stocks.
4D Molecular Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| AKRO | Akero Therapeutics, Inc. |
| GOSS | Gossamer Bio, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| RVMD | Revolution Medicines, Inc. Warrant |
| MLYS | Mineralys Therapeutics, Inc. |
| BMEA | Biomea Fusion, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| IPSC | Century Therapeutics, Inc. |
| BDTX | Black Diamond Therapeutics, Inc. |
| REPL | Replimune Group, Inc. |
| BCEL | Atreca, Inc. |
| KRON | Kronos Bio, Inc. |
| PASG | Passage Bio, Inc. |
| CCCC | C4 Therapeutics, Inc. |
| FIXX | Q32 Bio Inc. |
| LYRA | Lyra Therapeutics, Inc. |
| NVCT | Nuvectis Pharma, Inc. |
FDMT Ownership FAQ
Who Owns 4D Molecular Therapeutics?
4D Molecular Therapeutics is owned by institutional shareholders (116.37%), insiders (3.48%), and public (-19.85%). The largest institutional shareholder of 4D Molecular Therapeutics is RA CAPITAL MANAGEMENT, L.P. (10.35% of total shares) and the top mutual fund owner is CORNERCAP GROUP OF FUNDS /VA/ (0.14% of total shares).
Who are the major institutional shareholders of 4D Molecular Therapeutics?
4D Molecular Therapeutics's major institutional shareholders are RA CAPITAL MANAGEMENT, L.P., BLACKROCK INC., VR ADVISER, LLC, GOLDMAN SACHS GROUP INC, and DEEP TRACK CAPITAL, LP. The top five shareholders own together 45.85% of the company's share outstanding.
How many 4D Molecular Therapeutics shareholders are there?
As of Jun 2024, there are 146 institutional shareholders of 4D Molecular Therapeutics.
What percentage of 4D Molecular Therapeutics is owned by RA CAPITAL MANAGEMENT, L.P?
RA CAPITAL MANAGEMENT, L.P owns 5.1M shares of 4D Molecular Therapeutics, representing 10.35% of the company's total shares outstanding, valued at $107.01M (as of Jun 2024).
What percentage of 4D Molecular Therapeutics is owned by BLACKROCK INC?
As of Jun 2024, BLACKROCK INC holds 4.9M shares of 4D Molecular Therapeutics (FDMT), compromising 9.94% of the company, valued at $102.79M.
What percentage of 4D Molecular Therapeutics is owned by VR ADVISER, LLC?
VR ADVISER, LLC is the third largest holder of 4D Molecular Therapeutics. The company owns 4.4M of the company's shares outstanding (worth $92.36M).